ScienceDaily: Latest Science News
Researchers have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy.Sent with Reeder
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment